Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Manufacturing and Sales			200.23B	209.29B	189.24B	197.75B	189.72B
Total			200.23B	209.29B	189.24B	197.75B	189.72B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			160.32B	196.17B	179.78B	187.33B	180.10B
Vietnam			13.93B	-	-	-	-
Myanmar			1.29B	-	-	-	-
Philippines			1.82B	-	-	-	-
Japan			12.89B	-	-	-	-
Others			9.99B	-	-	-	-
Overseas			-	16.62B	9.45B	10.42B	9.63B
Unallocated			-	-3.50B	-	-	-
Total			200.23B	209.29B	189.24B	197.75B	189.72B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error